Phase II trial of high-dose dexamethasone for untreated patients with primary systemic amyloidosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase II trial of high-dose dexamethasone for untreated patients with primary systemic amyloidosis

Published:1999-07 Issue:2 Volume:16 Page:104-109
ISSN:0736-0118
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Gertz Morie A,Lacy Martha Q,Lust John A,Greipp Philip R,Witzig Thomas E,Kyle Robert A

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy,Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/BF02785843.pdf

Reference46 articles.

1. Merlini G. Treatment of primary amyloidosis.Semin Hematol 1995;32: 60–79.

2. Kyle RAet al. Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989.Blood 1992;79: 1817–1822.

3. Kyle RA, Beard CM, O'Fallon WM, Kurland LT. Incidence of multiple myeloma in Olmsted County, Minnesota: 1978 through 1990, with a review of the trend since 1945.J Clin Oncol 1994;12: 1577–1583.

4. Isobe T, Osserman EF. Patterns of amyloidosis and their association with plasma-cell dyscrasia monoclonal immunoglobulins and Bence-Jones proteins.N Engl J Med 1974;290: 473–477.

5. Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases.Semin Hematol 1995;32: 45–59.

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A randomized phase 3 study of ixazomib–dexamethasone versus physician’s choice in relapsed or refractory AL amyloidosis;Leukemia;2021-06-24

2. Immunoglobulin Light Chain Systemic Amyloidosis;Plasma Cell Dyscrasias;2016

3. Autologous hematopoietic stem cell transplantation in light chain amyloidosis (AL) with renal involvement;Bone Marrow Transplantation;2015-10-19

4. Treatment of Immunoglobulin Light Chain Amyloidosis;Mayo Clinic Proceedings;2015-08

5. Guidelines on the management of AL amyloidosis;British Journal of Haematology;2014-10-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3